{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:37:33Z","timestamp":1791581853850,"version":"4.3.4"},"reference-count":512,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.critrevonc.2003.11.003","type":"journal-article","created":{"date-parts":[[2004,6,2]],"date-time":"2004-06-02T17:50:25Z","timestamp":1086198625000},"page":"223-261","source":"Crossref","is-referenced-by-count":70,"title":["Adult acute lymphoblastic leukaemia"],"prefix":"10.1016","volume":"50","author":[{"given":"Renato","family":"Bassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2003.11.003_BIB1","unstructured":"Ferlay J, Bray F, Sankila R, et al. Cancer incidence, mortality and prevalence in the European Union. Lyon: IARC Press; 1999."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB2","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality and prevalence worldwide, version 1.0. Lyon: IARC Press, IARC Cancer Base No. 5; 2001."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB3","unstructured":"Stewart BW, Kleihus P, editors. World cancer report. Lyon: IARC Press; 2003."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB4","unstructured":"Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. VIII. IARC Scientific Publication No. 155. Lyon: International Agency for Research on Cancer; 2002."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB5","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0959-8049(98)00339-6","article-title":"Variation in survival of adult patients with haematological malignancies in Europe since 1978. EUROCARE Working Group","volume":"34","author":"Carli","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB6","unstructured":"Berrino F, Capocaccia R, Coleman MP, Esteve J, Gatta G, Hakulinen T, et al. Survival of cancer patients in Europe: the EUROCARE-3 Study. Ann Oncol 2003."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/annonc\/mdf127","article-title":"Cancer prevalence in European registry areas","volume":"13","author":"Micheli","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ijc.10406","article-title":"Radiation-induced leukemia risk among those aged 0\u201320 at the time of the Chernobyl accident: a case-control study in the Ukraine","volume":"99","author":"Noshchenko","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB9","unstructured":"Smith MA, Gloecker Ries LA, Gurney JG, Ross JA. Leukaemia in cancer incidence and survival among children and adolescents: United Stated SEER Program 1975\u20131995. NCI, SEER Pediatric Cancer Monograph; 1999."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB10","unstructured":"Little J. Epidemiology of childhood cancer. IARC Scientific Publication No. 149, Lyon: International Agency for Research on Cancer; 1999."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB11","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0889-8588(05)70183-0","article-title":"Pathologic diagnosis of acute lymphocytic leukemia","volume":"14","author":"Lai","year":"2000","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French\u2013American\u2013British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB13","unstructured":"Brunning RD, Flandrin G, Borowitz M. Precursor B lymphoblastic leukaemia\/lymphoblastic lymphoma (precursors B-cell acute lymphoblastic leuaemia). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics of tumours of the hhaematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 111\u20134."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB14","unstructured":"Brunning RD, Flandrin G, Borowitz M. Precursor T lymphoblastic leukaemia\/lymphoblastic lymphoma (precursors T-cell acute lymphoblastic leuaemia). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics of tumours of the hhaematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 115\u20137."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.leu.2401032","article-title":"Acute lymphoblastic leukemia with maturation--a new entity with clinical significance","volume":"12","author":"Kim","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB16","first-page":"233","article-title":"Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells","volume":"6","author":"Hurwitz","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB17","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0889-8588(05)70185-4","article-title":"Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease","volume":"14","author":"Huh","year":"2000","journal-title":"Hematol. Oncol. Clin North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","article-title":"Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia","volume":"351","author":"Coustan-Smith","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB19","first-page":"170","article-title":"The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases","volume":"3","author":"Janossy","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB20","first-page":"3931","article-title":"Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364","volume":"93","author":"Czuczman","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-4608(98)00153-8","article-title":"Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis","volume":"109","author":"Khalidi","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-0609.2001.00320.x","article-title":"Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts","volume":"66","author":"De Waele","year":"2001","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB23","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1309\/C38D-D8J3-JU3E-V6EE","article-title":"The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination","volume":"117","author":"Thalhammer-Scherrer","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/10428199809092688","article-title":"PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucemies","volume":"28","author":"Lenormand","year":"1998","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB26","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/sj.leu.2401932","article-title":"Fine characterization of childhood and adult acute lymphoblastic leukemia (ALL) by a proB and preB surrogate light chain-specific mAb and a proposal for a new B cell ALL classification","volume":"14","author":"Lemmers","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB27","first-page":"665","article-title":"Molecular and phenotypic spectrum of de novo Philadelphia positive acute leukemia","volume":"4","author":"Lim","year":"1999","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB28","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/sj.leu.2401794","article-title":"The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement","volume":"14","author":"Pajor","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0145-2126(99)00147-2","article-title":"Increased CD38 expression is associated with favorable prognosis in adult acute leukemia","volume":"24","author":"Keyhani","year":"2000","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V94.2.754","article-title":"High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia","volume":"94","author":"Geijtenbeek","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0145-2126(81)90001-1","article-title":"Phenotypic heterogeneity and cellular origins of T cell malignancies","volume":"5","author":"Greaves","year":"1981","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB32","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/sj.leu.2401127","article-title":"High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia","volume":"12","author":"Rieder","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.V67.2.415.415","article-title":"Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia","volume":"67","author":"Bloomfield","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB34","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/blood.V76.8.1449.1449","article-title":"Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia","volume":"76","author":"Pui","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0002-9343(90)90175-D","article-title":"The importance of cytogenetic studies in adult acute lymphocytic leukemia","volume":"89","author":"Walters","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x","article-title":"Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party","volume":"96","author":"Secker-Walker","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB37","doi-asserted-by":"crossref","unstructured":"GFCH. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique. Blood 1996;87:3135\u201342.","DOI":"10.1182\/blood.V87.8.3135.bloodjournal8783135"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB38","first-page":"3983","article-title":"Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience","volume":"93","author":"Wetzler","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB39","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0889-8588(05)70184-2","article-title":"Cytogenetics in adult acute lymphocytic leukemia","volume":"14","author":"Wetzler","year":"2000","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.02643.x","article-title":"The Leukaemia Research Fund\/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management","volume":"113","author":"Harrison","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB41","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1182\/blood.V97.11.3581","article-title":"Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis","volume":"97","author":"Kolomietz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(01)00388-0","article-title":"Cytogenetic aberrations in adult acute lymphocytic leukemia: optimal technique may influence the results","volume":"128","author":"Pedersen","year":"2001","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB43","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.leu.2401580","article-title":"Investigation of clonal involvement of myeloid cells in Philadelphia-positive and high hyperdiploid acute lymphoblastic leukemia","volume":"13","author":"Kasprzyk","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood.V95.3.1007.003k35_1007_1013","article-title":"A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia","volume":"95","author":"Cobaleda","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.leu.2402060","article-title":"Adult precursor B-ALL with BCR\/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10* CD34* CD13 and CD38 expresssion","volume":"15","author":"Tabernero","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB46","first-page":"24","article-title":"Characterization of the blast cells in acute leukemia with translocation (4;11): report of eight additional cases and of one case with a variant translocation","volume":"1","author":"Hagemeijer","year":"1987","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB47","first-page":"370","article-title":"Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses","volume":"6","author":"Schardt","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB48","first-page":"363","article-title":"Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia","volume":"6","author":"Secker-Walker","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB49","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.V82.4.1086.1086","article-title":"Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study","volume":"82","author":"Borowitz","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB50","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V79.7.1781.1781","article-title":"Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia","volume":"79","author":"Privitera","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB51","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1182\/blood.V96.7.2543","article-title":"New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases","volume":"96","author":"Schneider","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB52","first-page":"613","article-title":"Pediatric leukemia\/lymphoma with t(8;14)(q24;q11)","volume":"6","author":"Lange","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB53","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V91.11.3995","article-title":"Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia","volume":"91","author":"Faderl","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB54","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.leu.2401430","article-title":"Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence associations and implications","volume":"13","author":"Dabaja","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB55","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/sj.leu.2402640","article-title":"Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia","volume":"16","author":"Mancini","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB56","first-page":"154","article-title":"Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial","volume":"87","author":"Ribera","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB57","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1200\/JCO.1992.10.4.606","article-title":"Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study","volume":"10","author":"Trueworthy","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB58","first-page":"4036","article-title":"Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children\u2019s cancer group","volume":"94","author":"Heerema","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V98.1.165","article-title":"Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations","volume":"98","author":"Langerak","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0950-3536(05)80200-8","article-title":"Genetic changes: relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia","volume":"7","author":"Cole-Sinclair","year":"1994","journal-title":"Baillieres Clin. Haematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2003.11.003_BIB61","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0889-8588(05)70186-6","article-title":"Insights into the biologic and molecular abnormalities in adult acute lymphocytic leukemia","volume":"14","author":"Faderl","year":"2000","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB62","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0037-1963(00)90018-0","article-title":"Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia","volume":"37","author":"Ferrando","year":"2000","journal-title":"Semin Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB63","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/315758a0","article-title":"Structural organization of the bcr gene and its role in the Ph\u2019 translocation","volume":"315","author":"Heisterkamp","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB64","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood.V82.10.2943.2943","article-title":"Detection of ALL-1\/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation","volume":"82","author":"Biondi","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB65","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1084\/jem.177.4.965","article-title":"Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T-cell receptor alpha\/beta lineage: T-cell receptor delta gene deletion mechanism affects multiple genes","volume":"177","author":"Breit","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB66","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1038\/sj.onc.1204401","article-title":"Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL","volume":"20","author":"Reichel","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB67","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2141.2002.03291.x","article-title":"ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype","volume":"116","author":"Alessandri","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB68","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.leu.2402249","article-title":"A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia","volume":"15","author":"Bernard","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB69","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/sj.leu.2402304","article-title":"Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data","volume":"15","author":"Gleissner","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB70","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1182\/blood.V89.10.3769","article-title":"Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children\u2019s Cancer Group Study","volume":"89","author":"Uckun","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB71","first-page":"1855","article-title":"The prognostic significance of p16INK4a\/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia","volume":"5","author":"Faderl","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB72","first-page":"4041","article-title":"Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia","volume":"5","author":"Faderl","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB73","first-page":"4062","article-title":"Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia","volume":"60","author":"Nakase","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB74","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1182\/blood.V95.6.1942","article-title":"Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications","volume":"95","author":"Wong","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB75","first-page":"2364","article-title":"Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia","volume":"95","author":"Stock","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB76","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V96.12.3922","article-title":"Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia","volume":"96","author":"Svingen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB77","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0145-2126(01)00042-X","article-title":"Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia","volume":"25","author":"Albitar","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB78","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/1097-0142(20010615)91:12<2222::AID-CNCR1252>3.0.CO;2-R","article-title":"Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance","volume":"91","author":"Chim","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0145-2126(00)00104-1","article-title":"MMP-2 and MMP-9 expression in adult and childhood acute lymphatic leukemia (ALL)","volume":"25","author":"Kuittinen","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB80","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2141.2001.02764.x","article-title":"Hypermethylation of the calcitonin gene in acute lymphoblastic leukaemia is associated with unfavourable clinical outcome","volume":"113","author":"Roman","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB81","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/sj.leu.2402153","article-title":"Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype","volume":"15","author":"Soenen","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB82","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood-2001-11-0093","article-title":"HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis","volume":"100","author":"Ballerini","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB83","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2141.2002.03451.x","article-title":"The absence of the p15INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a favourable prognostic factor","volume":"117","author":"Hoshino","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB84","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood.V99.7.2291","article-title":"5\u2032 cp. island hypermethylation is associated with transcriptional silencing of the p21(CIP1\/WAF1\/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia","volume":"99","author":"Roman-Gomez","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB85","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB86","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(85)92085-9","article-title":"Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemia","volume":"1","author":"Chan","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB87","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood.V68.4.900.900","article-title":"The contribution of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukemia","volume":"68","author":"Browman","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB88","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2141.1997.d01-2171.x","article-title":"Morphological and cytochemical findings in 150 cases of T-lineage acute lymphoblastic leukaemia in adults. German Multicentre ALL Study Group (GMALL)","volume":"97","author":"Gassmann","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB89","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.V77.6.1305.1305","article-title":"Ultrastructural demonstration of peroxidase expression in acute unclassified leukemias: correlation to immunophenotype and treatment outcome","volume":"77","author":"Heil","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB90","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2141.1992.tb06401.x","article-title":"The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry","volume":"80","author":"Buccheri","year":"1992","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB91","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1309\/HDUE-DN2E-B72E-JK99","article-title":"Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia","volume":"116","author":"Arber","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB92","first-page":"274","article-title":"Immunophenotype of leukemic blasts with small peroxidase-positive granules detected by electron microscopy","volume":"2","author":"Vainchenker","year":"1988","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.leu.2401305","article-title":"Genetic, phenotypic and clinical features of acute lymphoblastic leukemias expressing myeloperoxidase mRNA detected by RT-PCR","volume":"13","author":"Serrano","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB94","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V76.4.808.808","article-title":"Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy","volume":"76","author":"Kantarjian","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB95","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1309\/RWCG-E5T9-GU95-LEWE","article-title":"Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia","volume":"117","author":"Hans","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB96","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5858\/2000-124-0092-TDTNAL","article-title":"Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia","volume":"124","author":"Faber","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB97","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1096-8652(200103)66:3<189::AID-AJH1043>3.0.CO;2-A","article-title":"Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity","volume":"66","author":"Paietta","year":"2001","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB98","unstructured":"Henderson ES. Clinical manifestation and diagnosis. In: Henderson ES, Lister TA, editors. Leukemia. 5th ed. Philadelphia: WB Sanders; 1990. p. 291\u2013359."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB99","unstructured":"Hoelzer D. Diagnosis and treatment of adult acute lymphoblastic leukemia. In: Wiernik PH, Canellos GP, Kyle RA, Schiffer CA, editors. Neoplastic diseases of the blood. 2nd ed. New York: Churchill-Livingstone; 1991. p. 253\u2013303."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000040913","article-title":"Rheumatic manifestations preceding adult acute leukemia: characteristics and implication in course and prognosis","volume":"101","author":"Gur","year":"1999","journal-title":"Acta Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428190009053534","article-title":"Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management","volume":"39","author":"Porcu","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB102","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-9343(80)90286-7","article-title":"Acute tumor lysis syndrome. A review of 37 patients with Burkitt\u2019s lymphoma","volume":"68","author":"Cohen","year":"1980","journal-title":"Am. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB103","unstructured":"Bain BJ. Leukemia diagnosis. A guide to the FAB classification. Philadelphia: JB Lippincott; 1990."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB104","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0145-2126(02)00034-6","article-title":"Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors","volume":"26","author":"Thomas","year":"2002","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0889-8588(05)70199-4","article-title":"Burkitt\u2019s acute lymphocytic leukemia (L3ALL) in adults","volume":"15","author":"Fenaux","year":"2001","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB106","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/0959-8049(95)00343-H","article-title":"Risk analysis in acute lymphoblastic leukaemia: problems and pitfalls","volume":"31A","author":"Chessells","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB107","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V60.3.677.677","article-title":"Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients","volume":"60","author":"Baccarani","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB108","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood.V80.7.1813.1813","article-title":"Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome","volume":"80","author":"Taylor","year":"1992","journal-title":"Blood"},{"issue":"Suppl 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB109","first-page":"S4","article-title":"Why is age such an important independent prognostic factor in acute lymphoblastic leukemia?","volume":"11","author":"Perentesis","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.leu.2400959","article-title":"The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties","volume":"12","author":"Chessells","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB111","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.bjc.6690104","article-title":"Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based study","volume":"79","author":"Stiller","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB112","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/sj.leu.2401915","article-title":"Trends in mortality from leukemia in subsequent age groups","volume":"14","author":"Levi","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB113","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JCO.1988.6.1.34","article-title":"Acute lymphoid leukemia in adolescents: clinical and biologic features predict a poor prognosis--a Pediatric Oncology Group Study","volume":"6","author":"Crist","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB114","first-page":"87","article-title":"Presenting features and treatment outcome of adolescents with acute lymphoblastic leukemia","volume":"4","author":"Santana","year":"1990","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB115","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/1097-0142(19930515)71:10+<3377::AID-CNCR2820711741>3.0.CO;2-8","article-title":"Young adults 16\u201321 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment","volume":"71","author":"Nachman","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB116","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1023\/A:1026538713236","article-title":"Acute lymphoblastic leukaemia in puberty and adolescence","volume":"11","author":"van den","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB117","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2141.1994.tb04982.x","article-title":"Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen","volume":"88","author":"Kantarjian","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB118","first-page":"1643","article-title":"Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year period","volume":"9","author":"Ferrari","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB119","first-page":"1327","article-title":"Acute lymphoblastic leukemia in the elderly. A twelve-year retrospective, single center study","volume":"85","author":"Pagano","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB120","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1365-2141.2002.03506.x","article-title":"Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remission","volume":"117","author":"Faderl","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB121","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood.V67.3.689.689","article-title":"Clinical and laboratory characteristics of acute leukemia with the 4;1 translocation","volume":"67","author":"Mirro","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB122","first-page":"1898","article-title":"Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03\/87 and 04\/89","volume":"92","author":"Ludwig","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB123","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.V73.5.1247.1247","article-title":"Prethymic phenotype and genotype of pre-T (CD7+\/ER\u2212)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia","volume":"73","author":"Thiel","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB124","first-page":"161","article-title":"Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d\u2019Etude Immunologique des Leucemies","volume":"7","author":"Garand","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB125","first-page":"1406","article-title":"Poor prognosis of prethymic phenotype acute lymphoblastic leukemia (pre-T-ALL)","volume":"8","author":"Digel","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB126","first-page":"637","article-title":"Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia","volume":"5","author":"Drexler","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB127","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJM198704303161802","article-title":"Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia","volume":"316","author":"Sobol","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB128","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood.V77.10.2242.2242","article-title":"Prognostic value of lymphocyte surface markers in acute myeloid leukemia","volume":"77","author":"Ball","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB129","first-page":"2118","article-title":"Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience","volume":"8","author":"Boldt","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB130","first-page":"249","article-title":"CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia","volume":"9","author":"Thomas","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB131","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V84.5.1603.bloodjournal8451603","article-title":"Immunophenotype of adult acute lymphoblastic leukemia clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia","volume":"84","author":"Boucheix","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB132","first-page":"196","article-title":"Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance","volume":"5","author":"Secker-Walker","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB133","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V80.12.2983.2983","article-title":"Clinical significance of the BCR\u2013ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762)","volume":"80","author":"Westbrook","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB134","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1182\/blood.V79.11.3067.3067","article-title":"Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"79","author":"Barrett","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB135","first-page":"431","article-title":"Approaches to the treatment of Philadelphia-positive acute lymphoblastic leukemia","volume":"12","author":"Grigg","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB136","first-page":"664","article-title":"Adult Philadelphia-chromosome-positive acute lymphoblastic leukemia: experience of treatments during a ten-year period","volume":"8","author":"Annino","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB137","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9343(94)90049-3","article-title":"Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients","volume":"97","author":"Preti","year":"1994","journal-title":"Am. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB138","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1365-2141.1996.d01-1968.x","article-title":"Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia","volume":"95","author":"Rieder","year":"1996","journal-title":"Br. J. Haematol."},{"issue":"Suppl. 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB139","first-page":"S8","article-title":"Molecular subsets and prognostic factors in acute lymphoblastic leukemia","volume":"11","author":"Westbrook","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB140","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Arico","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB141","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.thj.6200032","article-title":"Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome\/BCR\u2013ABL rearrangements in B-precursor adult acute lymphoblastic leukemia","volume":"1","author":"Bassan","year":"2000","journal-title":"Hematol. J."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB142","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/10428190009148847","article-title":"Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia","volume":"36","author":"Faderl","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB143","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0889-8588(05)70198-2","article-title":"Philadelphia chromosome-positive acute lymphocytic leukemia","volume":"15","author":"Radich","year":"2001","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB144","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1182\/blood.V99.5.1536","article-title":"Leading prognostic relevance of the BCR\u2013ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis","volume":"99","author":"Gleissner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB145","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/bjc.1992.304","article-title":"Mdr1\/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias","volume":"66","author":"Gekeler","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB146","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1182\/blood.V82.11.3445.3445","article-title":"Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia\/acute lymphoblastic leukemia","volume":"82","author":"Miwa","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB147","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1182\/blood.V81.9.2394.2394","article-title":"Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications","volume":"81","author":"Goasguen","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB148","first-page":"881","article-title":"Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias","volume":"8","author":"Russo","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB149","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.0007-1048.2001.03322.x","article-title":"P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia","volume":"116","author":"Damiani","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB150","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood-2001-12-0371","article-title":"MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia","volume":"100","author":"Tafuri","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB151","first-page":"990","article-title":"Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias","volume":"8","author":"Burger","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB152","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2141.1995.tb03312.x","article-title":"Expression of mdr1 mrp topoisomerase II alpha\/beta and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias","volume":"89","author":"Beck","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB153","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood.V80.5.1158.1158","article-title":"Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia","volume":"80","author":"Trippett","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB154","first-page":"375","article-title":"Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis","volume":"6","author":"Pieters","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB155","first-page":"1000","article-title":"Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease","volume":"7","author":"Goker","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB156","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2141.1993.tb08652.x","article-title":"Cytostatic drug resistance: parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine\u2013DNA\u2013alkyltransferase and P-glycoprotein in adult patients with leukaemia","volume":"85","author":"Joncourt","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB157","first-page":"5251","article-title":"Expression of mu class glutathione-S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia","volume":"54","author":"Hall","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB158","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V86.2.677.bloodjournal862677","article-title":"Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations","volume":"86","author":"Goker","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB159","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V89.3.1013","article-title":"Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression","volume":"89","author":"Gorlick","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB160","first-page":"2730","article-title":"Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome","volume":"92","author":"Schrappe","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB161","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2141.2000.02028.x","article-title":"Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia","volume":"110","author":"Estlin","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB162","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1365-2141.2000.t01-1-02153.x","article-title":"The clinical and cellular pharmacology of vincristine, corticosteroids, l-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia","volume":"110","author":"Estlin","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2003.11.003_BIB163","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2141.2000.02211.x","article-title":"In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia","volume":"110","author":"Styczynski","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB164","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2141.2000.02070.x","article-title":"Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia","volume":"110","author":"Rots","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB165","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.leu.2402165","article-title":"The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"15","author":"Whitehead","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB166","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.leu.2402144","article-title":"Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance","volume":"15","author":"Schmiegelow","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB167","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.1995.tb05251.x","article-title":"Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia","volume":"91","author":"Maung","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB168","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/mpo.10087","article-title":"In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups","volume":"38","author":"Remakers-van Woerden","year":"2002","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB169","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199802193380803","article-title":"Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia","volume":"338","author":"Evans","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB170","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","article-title":"p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies","volume":"84","author":"Wattel","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB171","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood.V83.10.2922.2922","article-title":"Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase","volume":"83","author":"Hsiao","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB172","first-page":"955","article-title":"p53 gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24","volume":"9","author":"Lanza","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB173","first-page":"815","article-title":"Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic program","volume":"9","author":"Debatin","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB174","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1182\/blood.V87.12.4949.bloodjournal87124949","article-title":"Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1\/p16INK4A\/CDKN2, MTS2\/p15INK4B, p53, and Rb genes in primary lymphoid malignancies","volume":"87","author":"Hangaishi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB175","first-page":"1901","article-title":"Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies","volume":"10","author":"Tsai","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB176","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1182\/blood.V78.4.1125.1125","article-title":"Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation","volume":"78","author":"Miller","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB177","first-page":"1302","article-title":"Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review","volume":"7","author":"Potter","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB178","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.leu.2401780","article-title":"New definition of remission in childhood acute lymphoblastic leukemia","volume":"14","author":"Pui","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB179","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJM199310283291802","article-title":"Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia","volume":"329","author":"Uckun","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB180","first-page":"530","article-title":"The contribution of residual leukemic cells in the graft to leukemia relapse after autologous bone marrow transplantation: mathematical considerations","volume":"3","author":"Schultz","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB181","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.1993.tb03351.x","article-title":"Evaluation of leukaemic contamination in peripheral blood stem cell harvests by reverse transcriptase polymerase chain reaction","volume":"85","author":"Nagafuji","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB182","first-page":"615","article-title":"Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation","volume":"9","author":"Seriu","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB183","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1701976","article-title":"Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group","volume":"24","author":"Mizuta","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB184","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/blood.V85.6.1416.bloodjournal8561416","article-title":"Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance","volume":"85","author":"Campana","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB185","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1182\/blood.V92.11.4072","article-title":"Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia","volume":"92","author":"Knechtli","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB186","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood.V97.7.2115","article-title":"Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia","volume":"97","author":"Chen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB187","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJM198608283150902","article-title":"Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission","volume":"315","author":"Estrov","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB188","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1182\/blood.V87.12.5251.bloodjournal87125251","article-title":"Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia","volume":"87","author":"Brisco","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB189","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.1998.00574.x","article-title":"Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia","volume":"100","author":"Goulden","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJM199701303360501","article-title":"Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia","volume":"336","author":"Roberts","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB191","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB192","doi-asserted-by":"crossref","unstructured":"Cave H, van der Werff ten Bosch, Suciu S, Guidal C, Waterkeyn C, Otten J, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer\u2014Childhood Leukemia Cooperative Group. N Engl J Med 1998;339:591\u20138.","DOI":"10.1056\/NEJM199808273390904"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB193","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood.V96.8.2691","article-title":"Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"96","author":"Coustan-Smith","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB194","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V95.3.790.003k48_790_794","article-title":"Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia","volume":"95","author":"Panzer-Grumayer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB195","doi-asserted-by":"crossref","unstructured":"Stock W, Estrov Z. Studies of minimal residual disease in acute lymphocytic leukemia. Hematol Oncol Clin North Am 2000;14:1289-12ix.","DOI":"10.1016\/S0889-8588(05)70187-8"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB196","unstructured":"Brueggermann M, Droese J, Raff T, et al. The prognostic significance of minimal residual disease in adult standard risk patients with acute lymphoblastic leukemia. 2001;98:314a [abstract 1326]."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB197","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/sj.leu.2402091","article-title":"Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL","volume":"15","author":"Malec","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB198","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.20.4.1094","article-title":"Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia","volume":"20","author":"Mortuza","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB199","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","article-title":"Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome","volume":"99","author":"Nyvold","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB200","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1182\/blood.V77.11.2456.2456","article-title":"Direct correlation of cytogenetic findings with cell morphology using in situ hybridization: an analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukemia","volume":"77","author":"Anastasi","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB201","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.leu.2400589","article-title":"Increased sensitivity of minimal residual disease detection by interphase FISH in acute lymphoblastic leukemia with hyperdiploidy","volume":"11","author":"Kasprzyk","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB202","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ajcp\/111.6.759","article-title":"Posttherapy surveillance of B-cell precursor acute lymphoblastic leukemia. Value of polymerase chain reaction and limitations of flow cytometry","volume":"111","author":"Kallakury","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB203","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1200\/JCO.1998.16.12.3774","article-title":"Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia","volume":"16","author":"Ciudad","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB204","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.1999.01236.x","article-title":"Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL","volume":"104","author":"Ciudad","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2141.1999.01300.x","article-title":"Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome","volume":"105","author":"Griesinger","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB206","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.leu.2401279","article-title":"Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL","volume":"13","author":"Lucio","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB207","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<106::AID-MPO6>3.0.CO;2-L","article-title":"Population-based study of the pattern of molecular markers of minimal residual disease in childhood and adult acute lymphoblastic leukemia: an assessment of the practical difficulty of representative sampling for trial purposes. Northern Region Haematology Group","volume":"34","author":"Middleton","year":"2000","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB208","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.leu.2402150","article-title":"BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation","volume":"15","author":"Lucio","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB209","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood-2002-04-1130","article-title":"Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia","volume":"100","author":"Coustan-Smith","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB210","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood.V99.6.1952","article-title":"Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia","volume":"99","author":"Dworzak","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB211","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2002.3311a.x","article-title":"Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation","volume":"116","author":"Sanchez","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB212","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1365-2141.2000.02029.x","article-title":"Simultaneous detection and quantification of minimal residual disease in childhood acute lymphoblastic leukaemia using real-time polymerase chain reaction","volume":"109","author":"Kwan","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB213","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood.V84.11.3835.bloodjournal84113835","article-title":"Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission","volume":"84","author":"Janssen","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB214","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/sj.leu.2400841","article-title":"Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response","volume":"11","author":"Foroni","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB215","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","article-title":"Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes","volume":"12","author":"Pongers-Willemse","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB216","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.leu.2401071","article-title":"Immunoglobulin and T-cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease","volume":"12","author":"Szczepanski","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB217","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1999.01365.x","article-title":"Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis","volume":"105","author":"Foroni","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB218","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.leu.2401459","article-title":"Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"13","author":"Neale","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB219","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood.V96.6.2254","article-title":"The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype","volume":"96","author":"Brumpt","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB220","first-page":"96","article-title":"A prospective study of residual-disease monitoring of the ALL1\/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia","volume":"95","author":"Cimino","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB221","first-page":"3281","article-title":"Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology","volume":"60","author":"Nakao","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB222","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1046\/j.1365-2141.2000.02434.x","article-title":"Minimal residual disease studies are beneficial in the follow-up of TEL\/AML1 patients with B-precursor acute lymphoblastic leukaemia","volume":"111","author":"de","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB223","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood.V95.8.2651","article-title":"Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia","volume":"95","author":"Donovan","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB224","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/sj.leu.2401765","article-title":"T-cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct \u2018end-stage\u2019 recombinations: implications for minimal residual disease monitoring","volume":"14","author":"Szczepanski","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB225","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0145-2126(01)00130-8","article-title":"PCR-heteroduplex analysis of TCR gamma, delta and TAL-1 deletions in T-acute lymphoblastic leukemias: implications in the detection of minimal residual disease","volume":"26","author":"Nirmala","year":"2002","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB226","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.leu.2402636","article-title":"Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL","volume":"16","author":"van dV","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB227","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/sj.leu.2402475","article-title":"Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR","volume":"16","author":"van dV","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB228","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","article-title":"Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL","volume":"99","author":"Willemse","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB229","first-page":"329","article-title":"Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow","volume":"9","author":"van Rhee","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB230","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00062752-199704040-00004","article-title":"Advances in the detection of minimal residual disease","volume":"4","author":"Radich","year":"1997","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB231","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/sj.leu.2400567","article-title":"Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL)","volume":"11","author":"Preudhomme","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB232","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1365-2141.1999.01605.x","article-title":"Quantification of minimal residual disease in patients with BCR\u2013ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction","volume":"106","author":"Mitterbauer","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB233","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","article-title":"Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial","volume":"100","author":"Dombret","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB234","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.leu.2402483","article-title":"Quantification of minimal residual disease in patients with e1a2 BCR\u2013ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay","volume":"16","author":"Yokota","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB235","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/sj.leu.2401922","article-title":"Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group","volume":"14","author":"Biondi","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB236","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.1986.tb02201.x","article-title":"Treatment of acute lymphoblastic leukaemia in adults","volume":"64","author":"Barnett","year":"1986","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB237","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.1988.6.6.1014","article-title":"A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969","volume":"6","author":"Gaynor","year":"1988","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2003.11.003_BIB238","first-page":"193a","article-title":"Results of intensofied consolidation therapy in four consecutive German multicentre studies for adult ALL","volume":"82","author":"Hoelzer","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB239","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood.V71.1.123.123","article-title":"Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults","volume":"71","author":"Hoelzer","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood.V73.1.57.57","article-title":"Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy","volume":"73","author":"Hussein","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB241","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.1990.8.6.994","article-title":"Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia","volume":"8","author":"Kantarjian","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB242","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1182\/blood.V78.11.2814.2814","article-title":"Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report","volume":"78","author":"Linker","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB243","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.annonc.a057821","article-title":"Improved results of an intensified therapy in adult acute lymphocytic leukemia","volume":"2","author":"Lluesma-Gonalons","year":"1991","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB244","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811","volume":"85","author":"Larson","year":"1995","journal-title":"Blood"},{"issue":"Suppl. 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB245","first-page":"S24","article-title":"Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL)","volume":"11","author":"Linker","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB246","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0889-8588(05)70188-X","article-title":"Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)","volume":"14","author":"Gokbuget","year":"2000","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB247","first-page":"802a","article-title":"Intensification of induction and consolidation improves only subgroups of adult ALL: analysis of 1200 patients in GMALL study 05\/93.802a","volume":"98","author":"Goekbuget","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB248","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.thj.6200091","article-title":"Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups","volume":"2","author":"Bassan","year":"2001","journal-title":"Hematol. J."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB249","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V64.1.267.267","article-title":"Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B","volume":"64","author":"Gottlieb","year":"1984","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2003.11.003_BIB250","first-page":"199","article-title":"Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group","volume":"6","author":"Stryckmans","year":"1992","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"10.1016\/j.critrevonc.2003.11.003_BIB251","first-page":"186","article-title":"Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period","volume":"6","author":"Bassan","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB252","first-page":"933","article-title":"Institutional performance and dose intensity as prognostic factors in adult ALL","volume":"9","author":"Bassan","year":"1995","journal-title":"Leukemia"},{"issue":"suppl 1","key":"10.1016\/j.critrevonc.2003.11.003_BIB253","first-page":"56a","article-title":"Adult acute lymphoblastic leukemia (AALL). Comparison of weekly doxorubicin (WD) vs. three day schedule (TDS) for induction remission. Long-term results","volume":"82","author":"Candelaria","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB254","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/07357909809115774","article-title":"Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studies","volume":"16","author":"Koc","year":"1998","journal-title":"Cancer Invest."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB255","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/sj.leu.2402130","article-title":"Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study","volume":"15","author":"Hunault-Berger","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB256","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.1993.11.10.1990","article-title":"Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia","volume":"11","author":"Fiere","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB257","first-page":"425","article-title":"Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study","volume":"5","author":"Cuttner","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB258","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/10428199309054736","article-title":"Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcome","volume":"11","author":"Bassan","year":"1993","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB259","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2141.1999.01258.x","article-title":"Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia","volume":"104","author":"Bassan","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB260","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1496::AID-CNCR16>3.0.CO;2-#","article-title":"Intensive short-term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group","volume":"86","author":"Ifrah","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB261","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1182\/blood.V79.12.3267.3267","article-title":"Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells","volume":"79","author":"Berman","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB262","first-page":"832","article-title":"Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia","volume":"7","author":"Weiss","year":"1993","journal-title":"Leukemia"},{"issue":"suppl 1","key":"10.1016\/j.critrevonc.2003.11.003_BIB263","first-page":"144a","article-title":"The limit of dose-intensification in the treatment of sdult acute lymphoblastic leukemia despite grow-factor therapy","volume":"81","author":"Wernli","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB264","first-page":"376","article-title":"Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia","volume":"8","author":"Todeschini","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB265","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.leu.2400912","article-title":"Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin","volume":"12","author":"Todeschini","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB266","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0889-8588(05)70197-0","article-title":"High-dose anthracycline induction in adult acute lymphocytic leukemia","volume":"15","author":"Todeschini","year":"2001","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB267","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.leu.2402526","article-title":"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study","volume":"16","author":"Takeuchi","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB268","doi-asserted-by":"crossref","unstructured":"Kantarjian HM. Adult acute lymphocytic leukemia. Future research directions. Hematol Oncol Clin North Am 2001;15:207\u201311, viii.","DOI":"10.1016\/S0889-8588(05)70205-7"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB269","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00686263","article-title":"Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without l-asparaginase for adult acute lymphoblastic leukemia","volume":"33","author":"Nagura","year":"1994","journal-title":"Cancer Chemother Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2003.11.003_BIB270","first-page":"182","article-title":"GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results","volume":"6","author":"Mandelli","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB271","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01834381","article-title":"Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia","volume":"70","author":"Thomas","year":"1995","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB272","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2141.1997.3613175.x","article-title":"Intensification of treatment for adults with acute lymphoblastic leukaemia: results of UK Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults","volume":"99","author":"Durrant","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB273","first-page":"2677","article-title":"A phase II \u201cwindow\u201d study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia","volume":"4","author":"Gore","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB274","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0925-5710(98)00075-9","article-title":"Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group","volume":"68","author":"Ueda","year":"1998","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.1998.00559.x","article-title":"Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a \u2018pre-induction\u2019 course for rapid tumour reduction: preliminary results on 66 patients","volume":"100","author":"Daenen","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB276","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jjco\/29.7.340","article-title":"Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group","volume":"29","author":"Kobayashi","year":"1999","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB277","first-page":"1088","article-title":"Fractionated cyclophosphamide added to the IVAP regimen (idarubicin\u2013vincristine\u2013l-asparaginase\u2013prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study","volume":"84","author":"Bassan","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB278","doi-asserted-by":"crossref","unstructured":"Larson RA. Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B. Hematol Oncol Clin North Am 2000;14:1367\u201379, x.","DOI":"10.1016\/S0889-8588(05)70191-X"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB279","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB280","doi-asserted-by":"crossref","unstructured":"Garcia-Manero G, Kantarjian HM. The hyper-CVAD regimen in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 2000;14:1381-13xi.","DOI":"10.1016\/S0889-8588(05)70192-1"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB281","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/10428190109057984","article-title":"Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia","volume":"41","author":"Cataland","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB282","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V99.3.863","article-title":"Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study","volume":"99","author":"Annino","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB283","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1365-2141.2002.03685.x","article-title":"High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia","volume":"118","author":"Hallbook","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB284","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.leu.2401007","article-title":"Hypersensitivity reactions to l-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia","volume":"12","author":"Larson","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB285","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1182\/blood.V96.5.1709","article-title":"Weekly polyethylene glycol conjugated l-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study","volume":"96","author":"Abshire","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB286","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1203::AID-CNCR15>3.0.CO;2-3","article-title":"Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia","volume":"86","author":"Aguayo","year":"1999","journal-title":"Cancer"},{"issue":"suppl 1","key":"10.1016\/j.critrevonc.2003.11.003_BIB287","first-page":"329a","article-title":"Modified Burkitt regimen for adult acute lymphocytic leukemia (ALL)","volume":"82","author":"Kantarjian","year":"1993","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2003.11.003_BIB288","first-page":"S130","article-title":"Follow-up of the first two successive German multicentre trials for adult ALL (01\/81 and 02\/84). German Adult ALL Study Group","volume":"7","author":"Hoelzer","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB289","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood.V81.5.1146.1146","article-title":"Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia","volume":"81","author":"Kantarjian","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB290","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/bjc.1990.317","article-title":"High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia","volume":"62","author":"Rohatiner","year":"1990","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB291","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1200\/JCO.1996.14.9.2480","article-title":"Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone","volume":"14","author":"Weiss","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB292","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8588(05)70196-9","article-title":"Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone","volume":"15","author":"Weiss","year":"2001","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB293","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB294","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","article-title":"Improved outcome in adult B-cell acute lymphoblastic leukemia","volume":"87","author":"Hoelzer","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB295","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1200\/JCO.2001.19.20.4014","article-title":"Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251","volume":"19","author":"Lee","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB296","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB297","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood.V86.2.444.bloodjournal862444","article-title":"Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial","volume":"86","author":"Ottmann","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB298","first-page":"1556","article-title":"A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111","volume":"92","author":"Larson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB299","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/blood.V90.2.590","article-title":"Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia\u2014a randomized phase-III study","volume":"90","author":"Geissler","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB300","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/10428199709109170","article-title":"Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs","volume":"26","author":"Bassan","year":"1997","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB301","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cncr.10241","article-title":"Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen","volume":"94","author":"Weiser","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB302","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/sj.leu.2401837","article-title":"Participation of granulocyte colony-stimulating factor in the growth regulation of leukemia cells from Philadelphia chromosome-positive acute leukemia and blast crisis of chronic myeloid leukemia","volume":"14","author":"Inukai","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB303","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<330::AID-AJH14>3.0.CO;2-B","article-title":"Granulocyte colony-stimulating factor (G-CSF) mediated mobilization of leukemic cells in Philadelphia chromosome positive acute lymphoblastic leukemia expressing myeloid antigens (my + Ph + ALL)","volume":"58","author":"Kobbe","year":"1998","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB304","first-page":"1","article-title":"Treatment of acute lymphoblastic leukemia","volume":"31","author":"Hoelzer","year":"1994","journal-title":"Semin Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB305","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/bjc.1986.32","article-title":"Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period","volume":"53","author":"Marcus","year":"1986","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB306","first-page":"222","article-title":"Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology","volume":"83","author":"Ribera","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB307","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.leu.2402006","article-title":"Comparison of the L10 M consolidation regimen to an alternative regimen including escalating methotrexate\/l-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study","volume":"15","author":"Petersdorf","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB308","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2002.07.116","article-title":"Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia","volume":"20","author":"Linker","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB309","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1200\/JCO.1991.9.11.2002","article-title":"The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B","volume":"9","author":"Ellison","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V55.2.199.199","article-title":"Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis","volume":"55","author":"Omura","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB311","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/blood.V72.5.1784.1784","article-title":"Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia","volume":"72","author":"Kantarjian","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB312","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1182\/blood.V86.6.2091.bloodjournal8662091","article-title":"The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia","volume":"86","author":"Cortes","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB313","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1005963732481","article-title":"Meningeosis leukaemica in adult acute lymphoblastic leukaemia","volume":"38","author":"Gokbuget","year":"1998","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB314","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0889-8588(05)70203-3","article-title":"Central nervous system involvement in adult acute lymphocytic leukemia","volume":"15","author":"Cortes","year":"2001","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB315","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cncr.10265","article-title":"Central nervous system relapse in adults with acute lymphoblastic leukemia","volume":"94","author":"Surapaneni","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB316","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V84.2.355.355","article-title":"Prevention and treatment of meningeal leukemia in children","volume":"84","author":"Pinkel","year":"1994","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.critrevonc.2003.11.003_BIB317","first-page":"178","article-title":"Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience","volume":"6","author":"Cassileth","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB318","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1200\/JCO.1986.4.8.1207","article-title":"Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin\u2019s lymphoma","volume":"4","author":"Morra","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB319","first-page":"1236","article-title":"Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen","volume":"7","author":"Wiernik","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB320","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.2002.03881.x","article-title":"Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid","volume":"119","author":"Takayama","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB321","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1200\/JCO.1997.15.2.476","article-title":"Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group","volume":"15","author":"Dekker","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB322","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0950-3536(05)80206-9","article-title":"Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults","volume":"7","author":"Patte","year":"1994","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB323","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V81.11.3158.3158","article-title":"Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor","volume":"81","author":"Bensinger","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB324","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0950-3536(05)80209-4","article-title":"Bone marrow transplantation for acute lymphoblastic leukaemia","volume":"7","author":"Barrett","year":"1994","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB325","first-page":"917","article-title":"Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study","volume":"17","author":"Fleming","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB326","first-page":"1009","article-title":"Allogeneic bone marrow transplantation for acute leukaemia\u2014IGCI experience. International Group for Chemo-Immunotherapy","volume":"17","author":"Labar","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB327","first-page":"13","article-title":"Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time\u2014a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)","volume":"17","author":"Frassoni","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB328","first-page":"114","article-title":"Allogeneic hematopoietic stem cell transplantation for acute leukemia","volume":"24","author":"Appelbaum","year":"1997","journal-title":"Semin. Oncol."},{"issue":"Suppl. 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB329","first-page":"S20","article-title":"Bone marrow transplantation for acute lymphocytic leukemia (ALL)","volume":"11","author":"Weisdorf","year":"1997","journal-title":"Leukemia"},{"issue":"Suppl. 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB330","first-page":"S12","article-title":"Bone marrow transplantation in first remission","volume":"11","author":"Rowe","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB331","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1046\/j.1365-2141.2001.02634.x","article-title":"Continuous complete remission in adult patients with acute lymphocytic leukaemia at a median observation of 12 years after autologous bone marrow transplantation","volume":"112","author":"Abdallah","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB332","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood.V76.10.2153.2153","article-title":"Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor","volume":"76","author":"Molineux","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB333","first-page":"351","article-title":"Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation","volume":"8","author":"Makrynikola","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB334","first-page":"285","article-title":"Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants","volume":"9","author":"Henon","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB335","first-page":"277","article-title":"Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants","volume":"9","author":"To","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB336","first-page":"469","article-title":"Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation","volume":"12","author":"Roberts","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB337","first-page":"241","article-title":"Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both","volume":"15","author":"Langenmayer","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB338","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/10428190009060323","article-title":"Autologous peripheral blood stem cell transplantation for adults with B-lineage acute lymphoblastic leukemia: a pilot study","volume":"38","author":"Muroi","year":"2000","journal-title":"Leuk. Lymphoma"},{"issue":"Suppl. 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB339","first-page":"S15","article-title":"Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL)","volume":"11","author":"Appelbaum","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB340","first-page":"896","article-title":"Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse","volume":"83","author":"Zikos","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB341","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bmt.1701064","article-title":"Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia","volume":"21","author":"Passweg","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB342","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V97.6.1572","article-title":"Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome","volume":"97","author":"Cornelissen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB343","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood.V98.6.1982","article-title":"The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia","volume":"98","author":"Uzunel","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB344","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1182\/blood.V69.1.361.361","article-title":"Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells","volume":"69","author":"Uckun","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB345","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood.V74.3.1152.1152","article-title":"Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma","volume":"74","author":"Preijers","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB346","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V76.9.1723.1723","article-title":"Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging","volume":"76","author":"Uckun","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB347","first-page":"255","article-title":"Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement","volume":"11","author":"Morishima","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB348","first-page":"243","article-title":"Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse","volume":"12","author":"Soiffer","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB349","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1182\/blood.V84.11.3810.bloodjournal84113810","article-title":"One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience","volume":"84","author":"Laporte","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB350","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1182\/blood.V91.6.2189","article-title":"Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation","volume":"91","author":"Rambaldi","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB351","unstructured":"Gilmore MJ, Hamon MD, Prentice HG, Katz F, IC, Hunter AE, et al. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission. Bone Marrow Transplant 1991;8:19\u201326."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB352","first-page":"535","article-title":"Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells","volume":"3","author":"Hagenbeek","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB353","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood.V66.3.508.508","article-title":"Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement","volume":"66","author":"Ramsay","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB354","first-page":"485","article-title":"Autologous bone marrow transplantation in acute lymphoblastic leukemia--preclinical immunologic studies","volume":"2","author":"Janossy","year":"1988","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB355","unstructured":"Martin H, Atta J, Hoelzer D. Autologous BMT\/PBSCT in BCR\u2013ABL-positive ALL: rationale for purging. In: Dicke CA, Keating A, editors. Autologous blood and bone marrow transplantation. Carden Jennings Publishing Co.; 1999. p. 84\u201392."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB356","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1701957","article-title":"Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement","volume":"24","author":"Granena","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB357","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.bmt.1702096","article-title":"Purging in BCR\u2013ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs. peripheral blood stem cells by semiquantitative polymerase chain reaction","volume":"25","author":"Atta","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB358","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0889-8588(05)70202-1","article-title":"Autologous stem cell transplantation for acute lymphocytic leukemia in adults","volume":"15","author":"Martin","year":"2001","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB359","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/stemcells.20-1-3","article-title":"Autologous stem cell transplantation in acute lymphocytic leukemia","volume":"20","author":"Gorin","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB360","first-page":"43","article-title":"Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey","volume":"11","author":"Weyman","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB361","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.bmt.1700964","article-title":"Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose ara-C and melphalan)","volume":"20","author":"Deconinck","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2003.11.003_BIB362","first-page":"94a","article-title":"Busulfan versus total body irradiation combined with cyclophosphamide as conditioning for autologous or allogenetic bone marrow transplantation in patients with acute leukemia","volume":"86","author":"Labopin","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB363","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.bmt.1701334","article-title":"Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan\/cyclophosphamide vs. total body irradiation: a meta-analysis","volume":"22","author":"Hartman","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB364","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.1996.d01-1681.x","article-title":"A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"93","author":"Ringden","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB365","unstructured":"Shank R. Radiotherapeutic principles of bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, editors. Bone marrow transplantation. Boston: Blackwell Scientific Publications; 1994. p. 96\u2013113."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB366","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1182\/blood.V78.11.2945.2945","article-title":"In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia","volume":"78","author":"Uckun","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB367","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood.V81.5.1323.1323","article-title":"Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts","volume":"81","author":"Uckun","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB368","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.bmt.1701498","article-title":"Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"22","author":"Kroger","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB369","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/sj.leu.2401589","article-title":"Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission","volume":"13","author":"Snyder","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB370","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0889-8588(05)70189-1","article-title":"The Medical Research Council trials in adult acute lymphocytic leukemia","volume":"14","author":"Durrant","year":"2000","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB371","first-page":"481a","article-title":"Favourable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): results from the international ALL trial (MRC UKALL XII\/ECOG E2993)","volume":"98","author":"Rowe","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB372","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0037-1963(01)90039-3","article-title":"Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience","volume":"38","author":"Pui","year":"2001","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB373","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB374","unstructured":"Bassan R. Management of infections in patients with leukemia. In: Henderson ES, Lister TA, Greaves MF, editors. Leukemia. 7th ed. Philadelphia: WB Saunders; 2002. p. 297\u2013362."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB375","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/infdis\/161.3.381","article-title":"From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever","volume":"161","author":"Hughes","year":"1990","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2003.11.003_BIB376","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0959-8049(05)80253-9","article-title":"Empirical antibiotic therapy in neutropenic cancer patients","volume":"29A","author":"Klastersky","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB377","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","article-title":"Management of fever in patients with cancer and treatment-induced neutropenia","volume":"328","author":"Pizzo","year":"1993","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB378","first-page":"405","article-title":"Management of infections in neutropenic patients: advances in therapy and prevention","volume":"6","author":"Karp","year":"1993","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB379","first-page":"132","article-title":"Infectious complications of patients undergoing therapy for acute leukemia: current status and future prospects","volume":"24","author":"Chanock","year":"1997","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB380","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.1995.13.1.165","article-title":"Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem","volume":"13","author":"Freifeld","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB381","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/infdis\/164.5.907","article-title":"Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis","volume":"164","author":"Sanders","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB382","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.36.5.1062","article-title":"Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study","volume":"36","author":"Ramphal","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB383","doi-asserted-by":"crossref","unstructured":"EORTC. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. J Infect Dis 1991;163:951\u20138.","DOI":"10.1093\/infdis\/163.5.951"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB384","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial","volume":"118","author":"Winston","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB385","doi-asserted-by":"crossref","first-page":"773","DOI":"10.7326\/0003-4819-99-6-773","article-title":"Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study","volume":"99","author":"Saral","year":"1983","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB386","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0140-6736(91)92098-M","article-title":"Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia","volume":"338","author":"Gmur","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB387","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2003.11.003_BIB388","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/10428199309064261","article-title":"Bleeding and thrombosis in acute lymphoblastic leukemia","volume":"11","author":"Barbui","year":"1993","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB389","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/10428199909058406","article-title":"Thrombosis related to the use of l-asparaginase in adults with acute lymphoblastic leukemia: a need to consider coagulation monitoring and clotting factor replacement","volume":"32","author":"Alberts","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB390","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.V79.5.1305.1305","article-title":"High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia","volume":"79","author":"Sarris","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB391","first-page":"1111","article-title":"Do G-CSF and GM-CSF contribute to the management of acute lymphoblastic leukemia?","volume":"10","author":"Ottmann","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB392","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0145-2126(98)00116-7","volume":"22","author":"Ottmann","year":"1998","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB393","first-page":"803a","article-title":"Improved outcome of high risk acute lymphoblastic leukemia (ALL) with late high dose therapy. A GOLEAM\u2019s trial","volume":"98","author":"Hunault","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB394","first-page":"689a","article-title":"Autologous stem cell transplantation for high-risk adult acute lymphoblastic leukemia (ALL)","volume":"98","author":"Linker","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-115-1-13","article-title":"Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission","volume":"115","author":"Horowitz","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB396","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.1994.12.12.2580","article-title":"Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia","volume":"12","author":"Sebban","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB397","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.V86.4.1619.bloodjournal8641619","article-title":"Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group","volume":"86","author":"Attal","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB398","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bmt.1701316","article-title":"Chemotherapy vs. HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission","volume":"22","author":"Oh","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB399","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0889-8588(05)70190-8","article-title":"Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87","volume":"14","author":"Thiebaut","year":"2000","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB400","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/sj.leu.2402289","article-title":"Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period","volume":"15","author":"Thomas","year":"2001","journal-title":"Leukemia"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2003.11.003_BIB401","first-page":"441a","article-title":"Chemotherapy (CHT), allogenic (ALLO) or autologous (AUTO) stem cell transplantation (SCT) for high risk ALL (HRALL). Results of the ongoing protocol PETHEMA-93","volume":"1","author":"Ribera","year":"2000","journal-title":"Hematol. J."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB402","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0145-2126(98)00085-X","article-title":"Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission","volume":"22","author":"Gale","year":"1998","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB403","first-page":"6","article-title":"Dose-intensive therapy for adult acute lymphoblastic leukemia","volume":"26","author":"Finiewicz","year":"1999","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB404","first-page":"241","article-title":"Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center","volume":"16","author":"Powles","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB405","first-page":"S18","article-title":"The role of allogeneic bone marrow transplantation in the treatment of high-risk acute lymphocytic leukemia in adults","volume":"11","author":"Forman","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB406","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1182\/blood-2002-03-0776","article-title":"The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia","volume":"100","author":"Powles","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB407","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0950-3536(05)80204-5","article-title":"Therapy and prognostic factors in adult acute lymphoblastic leukaemia","volume":"7","author":"Hoelzer","year":"1994","journal-title":"Baillieres Clin. Haematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2003.11.003_BIB408","first-page":"540","article-title":"New approaches to acute lymphoblastic leukemia in adults: where do we go?","volume":"27","author":"Hoelzer","year":"2000","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB409","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1988.6.2.227","article-title":"Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission","volume":"6","author":"Vernant","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB410","first-page":"583","article-title":"Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities","volume":"12","author":"Sutton","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB411","first-page":"383","article-title":"Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission","volume":"14","author":"Vey","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB412","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood.V78.8.1923.1923","article-title":"Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission","volume":"78","author":"Chao","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB413","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2141.2002.03403.x","article-title":"Influence of karyotype on outcome of allogeneic bone marrow transplantation for adults with precursor B-lineage acute lymphoblastic leukaemia in first or second remission","volume":"117","author":"Lee","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB414","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7326\/0003-4819-123-6-199509150-00006","article-title":"Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee","volume":"123","author":"Zhang","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB415","first-page":"517","article-title":"Autologous bone marrow transplantation for acute leukemia: results and prognostic factors in 90 consecutive patients","volume":"12","author":"Sierra","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB416","first-page":"315","article-title":"Autologous bone marrow transplantation for acute lymphoblastic leukemia","volume":"12","author":"Doney","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB417","first-page":"449","article-title":"Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia","volume":"12","author":"Tiley","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB418","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0950-3536(05)80210-0","article-title":"Autologous bone marrow transplantation in acute lymphoblastic leukaemia","volume":"7","author":"Carella","year":"1994","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB419","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0145-2126(01)00175-8","article-title":"Long-term follow-up of intensive ara-C-based chemotherapy followed by bone marrow transplantation for adult acute lymphoblastic leukemia: impact of induction ara-C dose and post-remission therapy","volume":"26","author":"Sotomayor","year":"2002","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB420","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings","volume":"15","author":"Szydlo","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB421","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.1998.16.3.931","article-title":"Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia","volume":"16","author":"Marks","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB422","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/sj.leu.2402712","article-title":"Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease","volume":"16","author":"Arnold","year":"2002","journal-title":"Leukemia"},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2003.11.003_BIB423","first-page":"36","article-title":"Mismatched transplant for acute lymphoblastic leukemia","volume":"18","author":"Aversa","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB424","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.thj.6200189","article-title":"Acute lymphoblastic leukemia in the elderly","volume":"3","author":"Annino","year":"2002","journal-title":"Hematol. J."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB425","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/10428199609051761","article-title":"Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemia","volume":"22","author":"Bassan","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB426","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.1083","article-title":"Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience","volume":"67","author":"Thomas","year":"2001","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB427","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1365-2141.1997.952909.x","article-title":"Prognostic factors in elderly acute lymphoblastic leukaemia","volume":"97","author":"Legrand","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB428","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/1097-0142(19910201)67:3<703::AID-CNCR2820670329>3.0.CO;2-6","article-title":"Pregnancy outcome in hematologic malignancies","volume":"67","author":"Zuazu","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB429","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archinte.137.1.90","article-title":"Successful treatment of acute leukemia during pregnancy. Combination therapy in the third trimester","volume":"137","author":"Durie","year":"1977","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB430","first-page":"19","article-title":"Chemotherapy for acute leukemia during pregnancy. Five case reports","volume":"26","author":"Fassas","year":"1984","journal-title":"Nouv. Rev. Fr. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB431","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0029-7844(00)01170-4","article-title":"Leukemia in pregnancy and fetal response to multiagent chemotherapy","volume":"97","author":"Hansen","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB432","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/1097-0142(19950915)76:6<985::AID-CNCR2820760611>3.0.CO;2-G","article-title":"Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes","volume":"76","author":"Chucrallah","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB433","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood.V60.5.1224.1224","article-title":"Treatment of refractory adult lymphoblastic leukemia (ALL) with 4\u2032(9-acridinylamino) methanesulfon-M-anisidide (AMSA)","volume":"60","author":"Arlin","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB434","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/1097-0142(19900815)66:4<627::AID-CNCR2820660404>3.0.CO;2-0","article-title":"Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy","volume":"66","author":"Milpied","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB435","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/1097-0142(19920201)69:3<709::AID-CNCR2820690318>3.0.CO;2-G","article-title":"Treatment of relapsed or refractory adult acute lymphocytic leukemia","volume":"69","author":"Freund","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB436","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ajh.2830450413","article-title":"Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults","volume":"45","author":"Welborn","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB437","first-page":"538","article-title":"Tailored therapy for relapsed or refractory childhood acute lymphoblastic leukemia","volume":"9","author":"Henze","year":"1995","journal-title":"Leukemia"},{"issue":"Suppl 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB438","first-page":"S28","article-title":"Treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL)","volume":"11","author":"Weiss","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB439","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.leu.2401058","article-title":"A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia","volume":"12","author":"Weiss","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB440","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2141.1994.tb03252.x","article-title":"Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA\/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell\u2019Adulto. Associazione Italiana Ematologia ed Ocologia Pediatrica","volume":"86","author":"Giona","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB441","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.V79.4.876.bloodjournal794876","article-title":"Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia","volume":"79","author":"Kantarjian","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB442","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1046\/j.1365-2141.1997.1102926.x","article-title":"Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol","volume":"97","author":"Giona","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB443","first-page":"637","article-title":"Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM)","volume":"4","author":"Hiddemann","year":"1990","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB444","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/sj.leu.2400861","article-title":"The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia","volume":"11","author":"Koller","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB445","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/10428199709039047","article-title":"Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF)","volume":"25","author":"Montillo","year":"1997","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB446","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/10428199809059249","article-title":"Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups","volume":"32","author":"Giona","year":"1998","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB447","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O","article-title":"Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy","volume":"86","author":"Thomas","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB448","first-page":"505","article-title":"Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial","volume":"84","author":"Martino","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB449","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0145-2126(99)00148-4","article-title":"A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia","volume":"24","author":"Rosen","year":"2000","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB450","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0889-8588(05)70204-5","article-title":"Salvage therapy for refractory or relapsed acute lymphocytic leukemia","volume":"15","author":"Garcia-Manero","year":"2001","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB451","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cncr.10707","article-title":"A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia","volume":"95","author":"Weiss","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB452","unstructured":"Chao NJ, Forman SJ. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia. In: Forman SJ, Blume KJ, Thomas ED, editors. Bone marrow transplantation. Boston: Blackwell Scientific Publications; 1994. p. 618\u201339."},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2003.11.003_BIB453","first-page":"214a","article-title":"Prtially matched related donor (PMRD) allogenetic bone marrow transplantation (BMT) in recurrent acute lymphoblastic leukemia (ALL)","volume":"84","author":"Fleming","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB454","first-page":"20","article-title":"Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults","volume":"81","author":"Bassan","year":"1996","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB455","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1182\/blood.V83.10.3077.3077","article-title":"Unrelated donor or autologous marrow transplantation for treatment of acute leukemia","volume":"83","author":"Busca","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB456","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/blood.V85.4.1122.bloodjournal8541122","article-title":"Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation","volume":"85","author":"Matthews","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB457","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2141.1996.4831024.x","article-title":"A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Societe Francaise de Greffe de Moelle Osseuse","volume":"93","author":"Cavazzana-Calvo","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB458","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/10428199509059629","article-title":"Autologous bone marrow transplantation for second or greater complete remission of acute myeloid leukaemia and acute lymphoblastic leukaemia","volume":"18","author":"Ager","year":"1995","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB459","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.1995.tb08360.x","article-title":"Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemia","volume":"89","author":"Carella","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB460","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.bmt.1701521","article-title":"FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission","volume":"22","author":"Deane","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB461","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.bmt.1701221","article-title":"Allogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemia","volume":"21","author":"Martino","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB462","first-page":"782","article-title":"Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy","volume":"87","author":"Mengarelli","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB463","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V90.8.2962","article-title":"Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia","volume":"90","author":"Weisdorf","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB464","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s002770100293","article-title":"Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias","volume":"80","author":"Kern","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB465","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.leu.2401335","article-title":"Decreased sensitivity of drug-resistant cells towards T cell cytotoxicity","volume":"13","author":"Classen","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB466","first-page":"967","article-title":"Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells","volume":"5","author":"Archimbaud","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB467","first-page":"724","article-title":"In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival","volume":"8","author":"Lauria","year":"1994","journal-title":"Leukemia"},{"issue":"Suppl. 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB468","first-page":"S36","article-title":"Use of cytokines in the treatment of acute lymphoblastic leukemia","volume":"11","author":"Nemunaitis","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB469","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood.V94.10.3531.422k14_3531_3540","article-title":"Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies","volume":"94","author":"Cardoso","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB470","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.leu.2402103","article-title":"Prospect for immunotherapy of acute lymphoblastic leukemia","volume":"15","author":"Velders","year":"2001","journal-title":"Leukemia"},{"issue":"Suppl. 4","key":"10.1016\/j.critrevonc.2003.11.003_BIB471","first-page":"S31","article-title":"Biologic response modifiers in acute lymphoblastic leukemia","volume":"11","author":"Gribben","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB472","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1365-2141.2002.03495.x","article-title":"Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells","volume":"117","author":"Lowdell","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB473","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/sj.leu.2401641","article-title":"Alpha-interferon improves survival and remission duration in P-190BCR\u2013ABL positive adult acute lymphoblastic leukemia","volume":"14","author":"Visani","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB474","first-page":"691","article-title":"Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia","volume":"15","author":"Beaujean","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB475","first-page":"662","article-title":"In vitro purging with BCR\u2013ABL antisense oligodeoxynucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantation","volume":"9","author":"de Fabritis","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB476","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI112450","article-title":"Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro","volume":"77","author":"Slater","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB477","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00689051","article-title":"Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833","volume":"36","author":"Gonzalez","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB478","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2141.1995.tb05162.x","article-title":"Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833","volume":"90","author":"Jiang","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB479","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood.V85.10.2675.bloodjournal85102675","article-title":"Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection","volume":"85","author":"Lacerda","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB480","first-page":"529","article-title":"ARA-C modulation by fludarabine: a strategy to overcome resistance to ARA-C","volume":"9","author":"Gandhi","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB481","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1182\/blood.V83.7.1731.1731","article-title":"Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia","volume":"83","author":"Manabe","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB482","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V85.10.2817.bloodjournal85102817","article-title":"In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells","volume":"85","author":"Uckun","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB483","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.2001.19.3.762","article-title":"Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia","volume":"19","author":"Giles","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB484","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1182\/blood.V97.11.3361","article-title":"Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial","volume":"97","author":"Karp","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB485","first-page":"3906","article-title":"Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor","volume":"5","author":"Uckun","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB486","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.leu.2401779","article-title":"Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro","volume":"14","author":"Herrera","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB487","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1702706","article-title":"Rituximab can be useful as treatment for minimal residual disease in bcr\u2013abl-positive acute lymphoblastic leukemia","volume":"27","author":"Jandula","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB488","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2141.2000.02402.x","article-title":"Molecular remission of Philadelphia\/bcr\u2013abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)","volume":"111","author":"de Vetten","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB489","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr\u2013Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB490","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR\u2013ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB491","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR\u2013ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB492","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.thj.6200151","article-title":"The ABL tyrosine kinase inhibitor STI571 (Glivec) in Philadelphia positive acute lymphoblastic leukemia\u2014promises, pitfalls and possibilities","volume":"3","author":"Ottmann","year":"2002","journal-title":"Hematol. J."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB493","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.leu.2402770","article-title":"Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"16","author":"Wassmann","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB494","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood.V96.9.3195","article-title":"Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr\u2013abl-positive cells","volume":"96","author":"Thiesing","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB495","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V96.6.2246","article-title":"CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr\u2013Abl-positive human leukemia cells to apoptosis due to antileukemic drugs","volume":"96","author":"Fang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB496","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/sj.leu.2402775","article-title":"Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs","volume":"16","author":"Tipping","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB497","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2002.03806.x","article-title":"Combination therapy with imatinib mesylate (STI571): synopsis of in vitro studies","volume":"119","author":"Topaly","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB498","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/sj.leu.2402729","article-title":"Efficacy of imatinib mesylate (STI571) in conjunction with alpha-interferon: long-term quantitative molecular remission in relapsed P-190(BCR\u2013ABL)-positive acute lymphoblastic leukemia","volume":"16","author":"Visani","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB499","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood.V99.9.3472","article-title":"High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR\/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance","volume":"99","author":"Branford","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB500","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB501","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(02)07678-X","article-title":"Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study","volume":"359","author":"Hofmann","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB502","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0277-5379(91)90382-N","article-title":"Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemia","volume":"27","author":"Bassan","year":"1991","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB503","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0360-3016(01)01513-9","article-title":"Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis","volume":"50","author":"Chan","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB504","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1008297130258","article-title":"Comparison of psychosocial adaptation of advanced stage Hodgkin\u2019s disease and acute leukemia survivors. Cancer and Leukemia Group B","volume":"9","author":"Kornblith","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB505","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10428199309147369","article-title":"Active immunization of children with leukemia and other malignancies","volume":"9","author":"Ridgway","year":"1993","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB506","doi-asserted-by":"crossref","unstructured":"Socie G, Stone JV, Wingard JR, Weisdorf D, P.J., Bredeson C, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999;341:14\u201321.","DOI":"10.1056\/NEJM199907013410103"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB507","unstructured":"Deeg HJ. Delayed complications after bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, editors. Bone transplantation. Boston: Blackwell Scientific Publications; 1994. p. 538\u201344."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB508","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V78.4.1147.1147","article-title":"Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II","volume":"78","author":"Pedersen-Bjergaard","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB509","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2141.1998.00616.x","article-title":"Secondary haematological neoplasm after treatment of adult acute lymphoblastic leukemia: analysis of 1170 adult ALL patients enrolled in the GIMEMA trials. Gruppo Italiano Malattie Ematologiche Maligne dell\u2019Adulto","volume":"100","author":"Pagano","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB510","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2141.2001.02788.x","article-title":"Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia","volume":"113","author":"Micallef","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB511","first-page":"1680","article-title":"l-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins","volume":"9","author":"Pui","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2003.11.003_BIB512","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1200\/JCO.1993.11.2.209","article-title":"Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide","volume":"11","author":"Winick","year":"1993","journal-title":"J. Clin. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842803002701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842803002701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T15:16:14Z","timestamp":1705158974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842803002701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":512,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1040842803002701"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2003.11.003","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}